Pharmaceutical formulations
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 9, 1997
Issued Date -
N/A
app pub date -
Aug 15, 1994
filing date -
Mar 29, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A Pharmaceutical formulation comprises a biologically active material such as insulin, erythropoietin, calcitonin and growth hormone, and, associated with it, a phospholipid for forming a material which participates in the alpha-glycerol or other pathways for the formation of lecithins which are found in the intestinal epithelial cell. Biologically active protein orally administered in such a formulation are bioavailable and bioactive.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully